JPMorgan vs. Waste Management: two buy-the-quality paths, one carries a bigger valuation question

JPMorgan Chase and Waste Management are showing up in the same conversation not because their businesses overlap, but because they have both generated strong long-term shareholder returns. In a recent market roundup, the comparison highlights how each company fits a different investor objective: JPMorgan’s model emphasizes capital returns and earnings growth, while Waste Management’s rests more heavily on decades of dividend discipline and recurring cash generation.

On JPMorgan’s side, the post points to share repurchases as a central element of the equity story. It says JPMorgan authorized a new $50 billion share repurchase program effective July 1, 2025, and it also cites a $50 billion buyback in the context of near-term shareholder support. It adds that JPMorgan announced a forward purchase commitment for the Apple Card portfolio in December 2025, positioning the move as part of how JPMorgan manages growth in consumer credit.

The same roundup ties those capital actions to reported operating momentum. It states that FY2025 revenue came in at $182.4 billion with earnings per share of $20.02, and it says Q1 2026 EPS was $5.94, up 17% year over year. The post also frames JPMorgan’s decade-long transformation as a key backdrop, portraying it as having expanded its role across American finance since the pandemic era and noting JPMorgan acquired First Republic in 2023 during the regional banking crisis.

Waste Management’s appeal, by contrast, is presented as steadier and more direct for investors focused on income and cash flow. The post says Waste Management has maintained a 23-year dividend streak, and it describes management’s focus on pricing discipline and route density as the operational engine behind the results. It also points to the company’s move into healthcare-related waste management, saying Waste Management acquired Stericycle in 2024 and 2025 and used the deal to create the WM Healthcare Solutions segment.

Financially, the post describes Waste Management as continuing to improve profitability and cash generation. It reports FY2025 revenue of $25.2 billion, up 14.2%, and says the company crossed a 30% adjusted EBITDA margin for the first time. For cash flow, it claims Q1 2026 free cash flow nearly doubled to $920 million, describing that as evidence the model can convert operating performance into shareholder cash beyond earnings.

The comparison also relies on stock-performance framing. It says that $1,000 invested in JPMorgan roughly 10 years ago grew to about $7,104 on price alone, and it contrasts that with the S&P 500’s $3,533 return over the same period in the post’s benchmark discussion. While the specific valuation argument is not quantified in the excerpted material, the headline thrust is that Waste Management’s dividend-and-cash approach may be easier to hold through cycles, whereas JPMorgan may be more sensitive to “dangerously expensive” pricing if expectations do not keep rising.

Still, important details are not fully disclosed in the post’s accessible text. The valuation concern is asserted without giving a clear metric in the excerpt (such as a specific forward price-to-earnings multiple, price-to-cash-flow ratio, or consensus growth-versus-price sensitivity). Similarly, the exact basis for the decade growth comparison beyond the $1,000-to-$7,104 and $3,533 figures is not elaborated, and the material does not specify whether the returns are purely price-based for both names in every window mentioned.

For investors tracking the debate, the near-term watch items are straightforward. For JPMorgan, the key question is whether buybacks and credit-related commitments like the Apple Card portfolio purchase plan can sustain earnings growth while the market remains willing to pay up. For Waste Management, the focus is whether healthcare integration under WM Healthcare Solutions continues to hold margins and cash conversion, while the company sustains its long dividend record. Over the next few quarters, updates on earnings and cash flow, along with any changes to capital return plans, are likely to determine whether the pricing gap between the two narratives widens or closes.